First Web-Seminar: Implementing ISO 17043:2023 - Guidelines for Laboratory PT Sample Production and Distribution
On June 5, 2024, QuoData successfully hosted a web-seminar on "Implementing ISO 17043:2023 - Guidelines for Laboratory PT Sample Production and Distribution." Martin Jähne, QuoData's Head of Laboratory, guided participants through the critical updates and changes in the ISO 17043:2023 standard.
The ISO 17043 standard, updated in 2023, includes several significant changes:
Incorporation of inspection and sampling as further conformity assessment activities in the standard
Q/Hampel Web service for PT providers
Please be aware that evaluation can take up to 4 hours1.
You will receive an email notification once the results are ready.
1The following business hours apply: Monday to Friday from 9:00 a.m. to 5:00 p.m. (UTC +2).
Formation of Cysteine Adducts with Chlorogenic Acid in Coffee Beans
Formation of Cysteine Adducts with Chlorogenic Acid in Coffee Beans
Tchewonpi, Sorel Sagu; Ulbrich, Nina; Morche, Johanna Rebekka; Nichani, Kapil, Özpinar, Haydar; Schwarz, Steffen; Henze, Andrea; Rohn, Sascha; Rawel, Harshadrai M. (2024)
Published in:
MetaInvert-ISO: QuoData Teams Up with Leading Institutions to Safeguard Soil Biodiversity
Exploring Artificial Intelligence for Life Science SMEs: Successful Event Hosted by QuoData with biosaxony
The "biosaxony vor Ort – AI for SMEs" event held on March 14, 2024, at the QuoData headquarters, was a resounding success. Filled with vibrant energy from enthusiastic participants and insights shared by esteemed speakers, it was an enriching experience.
The event kicked off with a brief opening by Conny Lerche, followed by Anja Rösler's introduction to biosaxony and its current initiatives. Continuing the program, QuoData’s Senior Data Scientist, Kapil Nichani, delved into "Embracing AI: Transforming measurement data into insights and actions".
Relevance of tumor markers for prognosis and predicting therapy response in non-small cell lung cancer patients: A CEPAC-TDM biomarker substudy
Relevance of tumor markers for prognosis and predicting therapy response in non-small cell lung cancer patients: A CEPAC-TDM biomarker substudy
Geiger, Kimberly; Joerger, Markus; Roessler, Max; Hettwer, Karina; Ritter Christoph; Simon, Kirsten; Uhlig, Steffen; Holdenrieder, Stefan (2024)
Exploring AI in Life Sciences: QuoData hosts "biosaxony vor Ort"
Exploring AI in Life Sciences: QuoData hosts "biosaxony vor Ort"
QuoData is honored and excited to take the lead in hosting the upcoming "biosaxony vor Ort" event on March 14, 2024, from 4 pm to 6:25 pm at our headquarters on Prellerstrasse 14.
Missing prognostic value of soluble PD-1, PD-L1 and PD-L2 in lung cancer patients undergoing chemotherapy – A CEPAC-TDM biomarker substudy
Missing prognostic value of soluble PD-1, PD-L1 and PD-L2 in lung cancer patients undergoing chemotherapy – A CEPAC-TDM biomarker substudy
Geiger, Kimberly; Joerger, Markus; Roessler, Max; Hettwer, Karina; Ritter Christoph; Simon, Kirsten; Uhlig, Steffen; Holdenrieder, Stefan (2024)
Published in:
Tumor Biology: https://content.iospress.com/articles/tumor-biology/tub230015
The Emergence of Maia - An open-source tool for video analysis of iPSC-CMs
The Emergence of Maia - An open-source tool for video analysis of iPSC-CMs
There's a tremendous growth noticed in the studies of induced pluripotent stem-cells derived cardiomyocytes (iPSC-CMs). Biomedical image & signal processing techniques are increasingly used in the analysis of stem cell studies, regenerative & therapeutic medicines, organ-on-chip studies, etc.
QuoData's Analytical Quality Assurance Solutions - Trusted by U.S. FDA and U.S. NIST
The U.S. Food and Drug Administration (U.S. FDA) and the U.S. National Institue of Standards and Technology (NIST) put their trust in QuoData's Analytical Quality Assurance Solutions
Since its foundation in 1995, QuoData has acquired a wide range of customers and partners around the world through its reliability and expertise. Among them influential policy-making and standard-setting bodies in the United States like the U.S. FDA and NIST.